Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles
- PMID: 17212617
- DOI: 10.1111/j.1600-0404.2006.00721.x
Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles
Abstract
The presence of antibodies against muscle-specific receptor tyrosine kinase (MuSK) appears to define a subgroup of patients with myasthenia gravis (MG) characterized by weakness predominant in bulbar, facial and neck muscles compared with anti-acetylcholine receptor (AChR) antibody-positive MG. To investigate the patterns and severity of neuromuscular transmission failure in different muscles in MuSK-positive MG, we performed single fiber electromyography (SFEMG) in the facial (frontalis) and limb (extensor digitorum communis, EDC) muscles in three anti-Musk-positive patients, and compared results with those of 11 anti-AChR-positive patients. Only one of the three MuSK-positive patients had abnormal jitter in EDC, but all the three showed clearly increased jitter in the frontalis. By contrast, the AChR-positive patients showed similarly abnormal jitter for the two muscles. These results suggest that when the diagnosis of anti-MuSK-positive MG is suspected, SFEMG should be performed in most prominently affected muscles.
Similar articles
-
Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis.Muscle Nerve. 2006 Apr;33(4):500-4. doi: 10.1002/mus.20498. Muscle Nerve. 2006. PMID: 16392120
-
Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.Ann Neurol. 2008 Jun;63(6):782-9. doi: 10.1002/ana.21371. Ann Neurol. 2008. PMID: 18384168
-
Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis.Muscle Nerve. 2006 Apr;33(4):568-70. doi: 10.1002/mus.20491. Muscle Nerve. 2006. PMID: 16382443
-
[Methods for diagnosing seronegative myasthenia gravis].Rev Neurol. 2008 Mar 16-31;46(6):360-4. Rev Neurol. 2008. PMID: 18368681 Review. Spanish.
-
Seronegative myasthenia gravis.Semin Neurol. 2004 Mar;24(1):125-33. doi: 10.1055/s-2004-829589. Semin Neurol. 2004. PMID: 15229799 Review.
Cited by
-
MuSK Myasthenia Gravis-Potential Pathomechanisms and Treatment Directed against Specific Targets.Cells. 2024 Mar 21;13(6):556. doi: 10.3390/cells13060556. Cells. 2024. PMID: 38534400 Free PMC article. Review.
-
Bedside and laboratory diagnostic testing in myasthenia.J Neurol. 2022 Jun;269(6):3372-3384. doi: 10.1007/s00415-022-10986-3. Epub 2022 Feb 10. J Neurol. 2022. PMID: 35142871 Free PMC article. Review.
-
Treatment of MuSK-Associated Myasthenia Gravis.Curr Treat Options Neurol. 2014 Apr;16(4):283. doi: 10.1007/s11940-014-0283-8. Curr Treat Options Neurol. 2014. PMID: 24504626
-
Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.Neurol Clin. 2018 May;36(2):293-310. doi: 10.1016/j.ncl.2018.01.004. Neurol Clin. 2018. PMID: 29655451 Free PMC article. Review.
-
MuSK-Associated Myasthenia Gravis: Clinical Features and Management.Front Neurol. 2020 Jul 23;11:660. doi: 10.3389/fneur.2020.00660. eCollection 2020. Front Neurol. 2020. PMID: 32793097 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical